Roivant Sciences Ltd., 10% Owner at Myovant Sciences Ltd. (MYOV), bought 243,812 shares at $12.90 ($3.0M) on 2019-11-20, disclosed to the SEC on 2019-11-22.
Open-market purchase of $3.0M MYOV by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.90 | 121,906 | $1.6M | 52.0% |
| 2 | $11.80 | 103,613 | $1.2M | 40.5% |
| 3 | $12.38 | 18,293 | $226K | 7.5% |
| Total | $12.39 avg | 243,812 | $3.0M | 100% |
| Filing → |
| IMVT | BUY | 2023-10-04 | $58.0M | — | Filing → |
| IMVT | BUY | 2022-10-07 | $2.5M | — | Filing → |
| IMVT | BUY | 2020-09-04 | $12.5M | — | Filing → |